Skip to content

Clinical trials

Coronary Disease trials in China with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Disease Phase: Not applicable Country / region: China Clear all

80 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20083
20093
20102
20111
20126
20132
20144
20153
20176
20184
20194
20202
202110
20223
20239
20245
20257
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status31
Completed29
Not yet recruiting9
Recruiting8
Active, not recruiting1
Terminated1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beijing Anzhen Hospital4
China National Center for Cardiovascular Diseases3
Guangdong Provincial People's Hospital3
Nanjing First Hospital, Nanjing Medical University3
Shanghai MicroPort Medical (Group) Co., Ltd.3
The First Affiliated Hospital with Nanjing Medical University3
Xijing Hospital3
Beijing AmsinoMed Medical Device Co., Ltd2
Beijing Hospital2
Chinese Academy of Medical Sciences, Fuwai Hospital2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Disease80
Coronary Artery Disease10
Myocardial Ischemia9
Cardiovascular Diseases6
Acute Coronary Syndrome5
Angina, Stable3
Arteriosclerosis3
Heart Diseases3
Anxiety Disorders2
Atherosclerosis2

Trials

Showing 1 to 25 of 80. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.